Worldwide Melanoma Treatment Industry to 2027 - Players Include Novartis, Pfizer, Sanofi and AstraZeneca - ResearchAndMarkets.com
The "Melanoma Treatment Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.
- The "Melanoma Treatment Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.
- These changes are increasing the incidence of melanoma patients worldwide, raising the demand for proper methods of treatment.
- By type, cutaneous melanoma is widely spread globally caused by too much exposure to ultraviolet rays from the sun and indoor tanning.
- Merck joined AstraZeneca in developing and commercializing Koselugo as part of a deal that included the ovarian cancer drug Lynparza.